Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""United States Food and Drug Administration"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 61-80 z 4664
Tytuł:
Readability of medication guides for Food and Drug Administration-approved biologics in dermatology.
Autorzy:
Lau CB; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Boston University, Boston, MA, USA.
Smith GP; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Mar 22; Vol. 48 (4), pp. 388-389.
Typ publikacji:
Journal Article
MeSH Terms:
Biological Products*/therapeutic use
Dermatology*
United States ; Humans ; United States Food and Drug Administration ; Comprehension ; Drug Labeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database.
Autorzy:
Li H; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.
Zhang M; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.; West China School of Pharmacy, Sichuan University, Chengdu, China.
Jiao X; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.
Zhu Y; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Liu Y; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.; West China School of Pharmacy, Sichuan University, Chengdu, China.
Zeng L; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.
Wang H; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Zhang L; College of Computer Science, Sichuan University, Chengdu, China.
Zhang W; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China. .; Medical Big Data Center, Sichuan University, Chengdu, China. .
Zhang L; Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China. .; Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. .; NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, China. .; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Mar 18; Vol. 13 (1), pp. 4475. Date of Electronic Publication: 2023 Mar 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antifungal Agents*/adverse effects
Periostitis*
United States/epidemiology ; Humans ; Voriconazole/adverse effects ; Bayes Theorem ; Prospective Studies ; Adverse Drug Reaction Reporting Systems ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Mar 07; Vol. 80 (6), pp. 330.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Labeling*
Product Labeling*
Humans ; United States ; Safety ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights, October-December 2022.
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Mar 07; Vol. 80 (6), pp. e74-e75.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Labeling*
Product Labeling*
Humans ; United States ; Safety ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneurs.
Autorzy:
Pond MA; National Cancer Institute, Small Business Innovation Research Development Center, Rockville, Maryland, USA.
Narayanan D; National Cancer Institute, Small Business Innovation Research Development Center, Rockville, Maryland, USA.
Zhang K; National Cancer Institute, Small Business Innovation Research Development Center, Rockville, Maryland, USA.
Fau D; United States Food and Drug Administration, Center for Devices and Radiological Health, Office of Strategic Partnerships and Technology Innovation, Silver Spring, Maryland, USA.
Summers J; United States Food and Drug Administration, Center for Drug Evaluation and Research, Office of Oncologic Diseases, Silver Spring, Maryland, USA.
Carranza D; United States Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Silver Spring, Maryland, USA.
Weingarten M; National Cancer Institute, Small Business Innovation Research Development Center, Rockville, Maryland, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Mar; Vol. 16 (3), pp. 412-421. Date of Electronic Publication: 2023 Jan 22.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Small Business*
Medical Oncology*
United States ; Humans ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Arrhythmic events associated with immune checkpoint inhibitors therapy: A real-world study based on the Food and Drug Administration Adverse Event Reporting System database.
Autorzy:
Liu Y; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi, China.
Chen Y; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi, China.
Zeng Z; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi, China.
Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 6637-6648. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immune Checkpoint Inhibitors*/adverse effects
B7-H1 Antigen*
Male ; United States/epidemiology ; Humans ; Female ; Aged ; United States Food and Drug Administration ; Programmed Cell Death 1 Receptor ; Pharmacovigilance ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Nontrivial Analysis of Patient Safety Risk from Parenteral Drug- and Medical Device-Borne Endotoxin.
Autorzy:
Tidswell EC; Merck & Co., Inc., West Point, PA, 19486, USA. .
Pokaż więcej
Źródło:
Drugs in R&D [Drugs R D] 2023 Mar; Vol. 23 (1), pp. 65-76. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Patient Safety*
Endotoxins*
Humans ; United States ; Pharmaceutical Preparations ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gene Expression Profile as a Predictor of Seizure Liability.
Autorzy:
Lipponen A; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.; Expert Microbiology Unit, Finnish Institute for Health and Welfare, P.O. Box 95, FIN-70701 Kuopio, Finland.
Kajevu N; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Natunen T; Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Ciszek R; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Puhakka N; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Hiltunen M; Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Pitkänen A; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 18; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Adverse Drug Reaction Reporting Systems*
Drug-Related Side Effects and Adverse Reactions*
United States ; Animals ; Rats ; Transcriptome ; United States Food and Drug Administration ; Seizures
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regulatory scripting: Stakeholder participation in food and drug administration medical device advisory meetings.
Autorzy:
White SK; Departments of Public Health and Sociology, Simmons University, Boston, Massachusetts, United States of America.
Leiter V; Departments of Public Health and Sociology, Simmons University, Boston, Massachusetts, United States of America.
Le MH; Departments of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Helms CK; Departments of Public Health and Sociology, Simmons University, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 16; Vol. 18 (2), pp. e0281774. Date of Electronic Publication: 2023 Feb 16 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Stakeholder Participation*
Advisory Committees*
United States ; Humans ; United States Food and Drug Administration ; Policy Making ; Group Processes ; Device Approval
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database.
Autorzy:
Shu Y; Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ding Y; Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
He X; Department of Pharmacy, Pengzhou Second People's Hospital, Pengzhou, China.
Liu Y; Department of Pharmacy, Pengzhou People's Hospital, Pengzhou, China.
Wu P; Department of Pharmacy, Qionglai Maternal & Child Health and Family Planning Service Center, Qionglai, China.
Zhang Q; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3365-3375. Date of Electronic Publication: 2022 Jul 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Poly(ADP-ribose) Polymerase Inhibitors*/adverse effects
Aged ; Humans ; Middle Aged ; Databases, Factual ; Risk Assessment ; United States ; United States Food and Drug Administration ; Adverse Drug Reaction Reporting Systems
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Global Regulatory Review Needed for Cochlear Implants: A Call for FDA Leadership.
Autorzy:
Humphries T; Education Studies and Department of Communication, University of California at San Diego, La Jolla, CA, USA.
Kushalnagar P; Department of Psychology, Gallaudet University, Washington, DC, USA.
Mathur G; Department of Linguistics, Gallaudet University, Washington, DC, USA.
Napoli DJ; Department of Linguistics, Swarthmore College, Swarthmore, PA, USA. .
Rathmann C; Department of Deaf Studies and Sign Language Interpreting, Humboldt-Universität Zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Maternal and child health journal [Matern Child Health J] 2020 Nov; Vol. 24 (11), pp. 1345-1359.
Typ publikacji:
Journal Article
MeSH Terms:
Cochlear Implants/*standards
Global Health/*trends
United States Food and Drug Administration/*standards
Child ; Child, Preschool ; Cochlear Implantation/instrumentation ; Cochlear Implantation/methods ; Cochlear Implantation/trends ; Cochlear Implants/trends ; Device Approval ; Female ; Humans ; Infant ; Male ; United States ; United States Food and Drug Administration/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
US Food and Drug Administration regulatory approaches for xenotransplantation products and xenografts.
Autorzy:
Arcidiacono J; Center for Biologics Evaluation, Office of Tissues and Advanced Therapies, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Pokaż więcej
Źródło:
Xenotransplantation [Xenotransplantation] 2020 Nov; Vol. 27 (6), pp. e12626. Date of Electronic Publication: 2020 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Government Regulation*
United States Food and Drug Administration*
Heterografts/*standards
Transplantation, Heterologous/*standards
Animals ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of turbulence on transitional flow in the FDA's benchmark nozzle model using large-eddy simulation.
Autorzy:
Manchester EL; Department of Chemical Engineering, Imperial College London, London, UK.
Xu XY; Department of Chemical Engineering, Imperial College London, London, UK.
Pokaż więcej
Źródło:
International journal for numerical methods in biomedical engineering [Int J Numer Method Biomed Eng] 2020 Oct; Vol. 36 (10), pp. e3389. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Benchmarking*
Computer Simulation*
Models, Cardiovascular*
United States Food and Drug Administration*
Stress, Mechanical ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir.
Autorzy:
Merz SF; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany.
Bengtson CP; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany.
Tepohl C; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany.
Hagenston AM; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany.
Bading H; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany.
Bas-Orth C; Department of Neurobiology, Interdisciplinary Center for Neurosciences, Heidelberg University, Im Neuenheimer Feld 366, D-69120, Heidelberg, Germany. .; Department of Medical Cell Biology, Institute for Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, D-69120, Heidelberg, Germany. .
Pokaż więcej
Źródło:
Molecular brain [Mol Brain] 2020 Sep 14; Vol. 13 (1), pp. 124. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Approval*
Microscopy*
United States Food and Drug Administration*
Antiviral Agents/*pharmacology
Neurons/*metabolism
Neuroprotective Agents/*pharmacology
Quinolones/*pharmacology
Small Molecule Libraries/*pharmacology
Animals ; Cell Death/drug effects ; Cells, Cultured ; Channelrhodopsins/metabolism ; Excitatory Postsynaptic Potentials/drug effects ; HEK293 Cells ; Humans ; Membrane Potential, Mitochondrial/drug effects ; Mice, Inbred C57BL ; N-Methylaspartate/pharmacology ; Neurons/cytology ; Neurons/drug effects ; Neuroprotection/drug effects ; Optogenetics ; Receptors, AMPA/metabolism ; Receptors, Glutamate/metabolism ; Receptors, N-Methyl-D-Aspartate/metabolism ; Synapses/metabolism ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration.
Autorzy:
Liang F; Medical Oncology, Shanghai Cancer Center, Fudan University, 270 Dongan Road, Shanghai, 200032, China.; Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang S; Medical Oncology, Shanghai Cancer Center, Fudan University, 270 Dongan Road, Shanghai, 200032, China. .
Wang Q; Shanghai University of Engineering Science, Shanghai, China. .
Li W; Department of Medical oncology, the affiliated hospital of Qingdao University, Qingdao, China. li_.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Aug 31; Vol. 20 (1), pp. 823. Date of Electronic Publication: 2020 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Approval*
Quality of Life*
United States Food and Drug Administration*
Antineoplastic Agents/*therapeutic use
Immune Checkpoint Inhibitors/*therapeutic use
Neoplasms/*drug therapy
Humans ; Kaplan-Meier Estimate ; Patient Reported Outcome Measures ; Progression-Free Survival ; Randomized Controlled Trials as Topic ; Societies, Medical ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
Autorzy:
de la Torre BG; KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
Albericio F; School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa.; CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Department of Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2020 Feb 09; Vol. 25 (3). Date of Electronic Publication: 2020 Feb 09.
Typ publikacji:
Historical Article; Journal Article; Review
MeSH Terms:
Drug Approval/*statistics & numerical data
Drug Discovery/*statistics & numerical data
Drug Industry/*trends
United States Food and Drug Administration/*statistics & numerical data
Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/therapeutic use ; Biological Products/chemistry ; Biological Products/therapeutic use ; Drug Approval/history ; Drug Approval/legislation & jurisprudence ; Drug Combinations ; Drug Discovery/history ; Drug Industry/history ; Drugs, Investigational/chemistry ; Drugs, Investigational/therapeutic use ; History, 21st Century ; Humans ; Immunoconjugates/chemistry ; Immunoconjugates/therapeutic use ; Molecular Structure ; Oligonucleotides/chemistry ; Oligonucleotides/therapeutic use ; Peptides/chemistry ; Peptides/therapeutic use ; Structure-Activity Relationship ; United States ; United States Food and Drug Administration/history ; United States Food and Drug Administration/legislation & jurisprudence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer?
Autorzy:
Bode AM; The Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.
Roh E; The Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2020 Jul 11; Vol. 9 (7). Date of Electronic Publication: 2020 Jul 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Approval*
Ultraviolet Rays*
United States Food and Drug Administration*
Skin Neoplasms/*etiology
Skin Neoplasms/*prevention & control
Sunscreening Agents/*pharmacology
Animals ; Cell Proliferation/drug effects ; Female ; Humans ; Mice, Hairless ; Oncogenes ; Phosphorylation/drug effects ; Protein Kinases/metabolism ; Skin/drug effects ; Skin/radiation effects ; Skin Neoplasms/pathology ; Sunscreening Agents/chemistry ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration.
Autorzy:
Fagan P
Eissenberg T
Jones DM
Cohen JE
Nez Henderson P
Clanton MS
Pokaż więcej
Źródło:
The Journal of legal medicine [J Leg Med] 2020 Jul-Dec; Vol. 40 (3-4), pp. 293-320.
Typ publikacji:
Historical Article; Journal Article
MeSH Terms:
Government Regulation*
United States Food and Drug Administration*
Advisory Committees/*organization & administration
Tobacco Products/*legislation & jurisprudence
Tobacco Use/*legislation & jurisprudence
Advisory Committees/history ; Advisory Committees/statistics & numerical data ; History, 21st Century ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Next 10 Years of Federal Tobacco Regulation: A Road Map to Protect Public Health and Advance Health Equity.
Autorzy:
Lester JM
Pokaż więcej
Źródło:
The Journal of legal medicine [J Leg Med] 2020 Jul-Dec; Vol. 40 (3-4), pp. 355-368.
Typ publikacji:
Journal Article
MeSH Terms:
Government Regulation*
Public Health*
Public Policy*
United States Food and Drug Administration*
Tobacco Products/*legislation & jurisprudence
Tobacco Use/*legislation & jurisprudence
Health Equity ; United States ; Vaping/legislation & jurisprudence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 61-80 z 4664

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies